Cite

HARVARD Citation

    Li, D. et al. (2022). Advances in targeted therapy in non‐small cell lung cancer with actionable mutations and leptomeningeal metastasis. Journal of clinical pharmacy and therapeutics. pp. 24-32. [Online]. 
  
Back to record